Edition:
India

People: Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

85.75USD
18 Apr 2019
Change (% chg)

$0.05 (+0.06%)
Prev Close
$85.70
Open
$85.78
Day's High
$86.54
Day's Low
$84.32
Volume
412,462
Avg. Vol
337,125
52-wk High
$116.43
52-wk Low
$78.97

Doherty, Catherine 

Ms. Catherine T. Doherty is a Senior Vice President, Group Executive - Clinical Franchise Solutions and Marketing of the Company. Since January 2013, Ms. Doherty has been responsible for overseeing the development of clinical franchise solutions in the areas of cardiovascular, infectious disease and immunology, and prescription drug monitoring and toxicology, as well as enterprise-wide strategic marketing. From January 2013 to January 2017, she also was responsible for clinical franchise solutions in the areas of neurology, women's health and general wellness. In February 2014, Ms. Doherty assumed responsibility for the employer solutions and risk assessment businesses. From February 2014 to January 2017, she also was responsible for the healthcare information technology business. From May 2011 to December 2012, she served as Senior Vice President, Physician Services. Prior to May 2011, Ms. Doherty held a variety of positions of increasing responsibility since joining the Company in 1990, including Vice President, Hospital Services; Vice President, Office of the Chairman; Vice President, Finance and Administration for the Hospital business; Vice President, Communications and Investor Relations; and Chief Accounting Officer.

Basic Compensation

Total Annual Compensation, USD 994,175
Restricted Stock Award, USD 900,090
Long-Term Incentive Plans, USD --
All Other, USD 637,751
Fiscal Year Total, USD 2,532,020

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Stephen Rusckowski

10,348,000

Mark Guinan

3,460,400

James Davis

3,270,240

Gabrielle Wolfson

--

Michael Prevoznik

2,090,390

Jon Cohen

2,491,990
As Of  31 Dec 2017